Inactive Instrument
Arix Bioscience plc Stock
Stocks
ARIX
GB00BD045071
Investment Management & Fund Operators
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Tom Davidson
DFI | Director of Finance/CFO | - | 2023-04-30 |
Laura Craig
IRC | Investor Relations Contact | - | - |
Jade Fletcher
AUD | Comptroller/Controller/Auditor | - | 2022-10-09 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 2021-04-28 | |
| Director/Board Member | 63 | 2022-08-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/31/23 | Free | Chief Executive Officer | 671,800 | 0.5200% | ||
| 5/4/23 | Sell | Chief Executive Officer | 22,238 | 0.0172% | ||
| 5/4/23 | Sell | Chief Executive Officer | 57,000 | 0.0441% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -1.05% | - | - | 235M | |
| +1.85% | +7.06% | +1.73% | +86.98% | 174B | |
| +1.13% | +0.18% | +31.71% | +87.30% | 145B | |
| +1.11% | +5.96% | +36.31% | +250.10% | 97.07B | |
| -0.70% | +3.16% | -32.13% | +16.05% | 88.26B | |
| +0.30% | +2.97% | -16.84% | +87.46% | 83.41B | |
| +0.74% | +4.99% | -27.34% | +63.67% | 80.08B | |
| +0.12% | +1.75% | -15.61% | +55.00% | 73.41B | |
| +1.42% | +1.23% | +47.74% | +160.48% | 45.45B | |
| +0.58% | -1.07% | +2.33% | +57.12% | 43.08B | |
| Average | +0.66% | +1.16% | +3.10% | +96.02% | 92.26B | |
| Weighted average by Cap. | +0.86% | +1.93% | +3.76% | +96.01% |
Employees
9
